Background: Hemangioendothelioma (HE) represents a group of rare, borderline malignant vascular tumors with diverse clinical presentations and diagnostic challenges. This study aims to investigate the demographic, clinical, radiological data, histological findings, treatment modalities, survival rates, and other key ch...
M. Anbardar, Mohammad Ali Rahmani, A. Ameli et al.· Galen medical journal· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.